The Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Monomil® XL 60mg tablets are now available to meet normal demand. As a result the Serious Shortage Protocol (SSP), SSP059 Monomil® XL 60mg tablets expires at 23.59pm on Friday 7 June 2024. After this date, any prescriptions for Monomil® XL 60mg [...]
The post Expiry of SSP059 Monomil® XL 60mg tablets appeared first on Community Pharmacy England.
Drug alert number: EL (24)A/20 Date issued: 06 June 2024 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 medicines recall for: Lamotrigine Desitin 10mg/ml oral suspension (Desitin Pharma UK Ltd) PL 14040/0040 SNOMED Code: 42751111000001102 Batch No Expiry Date Pack Size First Distributed 024171A1 31/01/2026 300ml 07-May-24 024172A1 31/01/2026 300ml [...]
The post MHRA Class 2 Medicines Recall: Lamotrigine Desitin 10mg/ml oral suspension (Desitin Pharma UK Ltd) appeared first on Community Pharmacy England.
A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 17 Issue 9 April 2024) has been published and includes articles on: Topical steroids: introduction of new labelling and a reminder of the possibility of severe side effects, including Topical Steroid Withdrawal Reactions Letters and medicine recalls sent to healthcare professionals in [...]
The post MHRA Drug Safety Update: May 2024 appeared first on Community Pharmacy England.
Community Pharmacy England on behalf of pharmacy owners made further applications to the Department of Health and Social Care (DHSC) and the NHS Business Services Authority (NHSBSA), resulting in a further 11 new products being added to the ‘Drugs for which Discount is Not Deducted’ (DND) list from 1 June 2024. This takes the total [...]
The post 11 products added to the Discount Not Deducted (DND) list from June 2024 appeared first on Community Pharmacy England.
Class 4 Medicines Defect Information: Sodium Chloride 0.9% Intravenous Infusion BP Freeflex and Freeflex PLUS (Fresenius Kabi Limited) Drug alert number: EL (24)A/17 Date issued: 22 May 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Sodium Chloride 0.9% Intravenous Infusion BP Freeflex and Freeflex PLUS [...]
The post MHRA Class 4 Medicines Notification: Sodium Chloride 0.9% Intravenous Infusion BP Freeflex and Freeflex PLUS (Fresenius Kabi Limited) appeared first on Community Pharmacy England.
Recent Comments